PFIZER VACCINE PROTECTS CHILDREN AGAINST RARE COVID19 COMPLICATIONS : CDC

By Chandrayee Roy Choudhury, Canada: 

The centre for disease control and prevention says,

Two doses of the Pfizer Inc and BioNTech COVID-19 vaccine are highly protective against a rare but often serious condition in children that causes organ inflammation weeks after COVID-19 infections.

The vaccine was estimated to be 91% effective in preventing Multisystem Inflammatory Syndrome in Children (MIS-C) in 12- to 18-year-olds, the study said. MIS-C causes inflammation in children in organs including the heart, lungs, kidneys and brain two to six weeks after a mild or asymptomatic infection.

All 38 MIS-C patients requiring life support were unvaccinated, the study said.



The results add to a growing body of evidence that vaccination against COVID-19 is likely to prevent disease-related complications in children, including MIS-C, the report said.